A case of Hageman factor deficiency with myeloid leukaemia
McGrath, K.; Koutts, J.
Australian and New Zealand Journal of Medicine 5(2): 155-157
1975
ISSN/ISBN: 0004-8291 PMID: 1057927 Document Number: 93221
The co-existence of blastic transformation of chronic myeloid leukaemia and an isolated deficiency of coagulation factor XII (Hageman Factor), is reported. In the absence of any evidence of factor XII deficiency in the patient's siblings and children, it is uncertain if this represents an acquired factor XII deficiency due to myeloid leukaemia, or the coincidental occurrence of myeloid leukaemia with this autosomal recessive condition.
Document emailed within 1 workday
Related Documents
Stopera, S.A.; Ray, M. 1989: Expression and distribution of aphidicolin-induced fragile sites in chronic myeloid leukaemia, acute lymphocytic leukaemia and acute myeloid leukaemia Cytobios 60(241): 103-109Martinez Canaveri, A.; Jamardo, N.; Ferraris, J.R.; Taffuni, M.; Albores, J.M. 1974: Acquired deficiency of Hageman factor (factor XII) Medicina 34(3): 223-228
Martinić, P.; Dubravcić, M.; Vucenik, I. 1978: Factor XII deficiency - Hageman trait. Report of 2 cases Bilten Za Hematologiju i Transfuziju 6(1): 29-34
Halbmayer, W.M.; Haushofer, A.; Schön, R.; Mannhalter, C.; Strohmer, E.; Baumgarten, K.; Fischer, M. 1994: The prevalence of moderate and severe FXII (Hageman factor) deficiency among the normal population: evaluation of the incidence of FXII deficiency among 300 healthy blood donors Thrombosis and Haemostasis 71(1): 68-72
Melo, J.V.; Goldman, J.M. 1992: Specific point mutations that activate v-abl are not found in Philadelphia-negative chronic myeloid leukaemia, Philadelphia-negative acute lymphoblastic leukaemia or blast transformation of chronic myeloid leukaemia Leukemia 6(8): 786-790
Cole, S.R.; Aylett, G.W.; Harvey, N.L.; Cambareri, A.C.; Ashman, L.K. 1996: Increased expression of c-Kit or its ligand Steel Factor is not a common feature of adult acute myeloid leukaemia Leukemia 10(2): 288-296
Gordon, M.Y.; Atkinson, J.; Clarke, D.; Dowding, C.R.; Goldman, J.M.; Grimsley, P.G.; Siczkowski, M.; Greaves, M.F. 1991: Deficiency of a phosphatidylinositol-anchored cell adhesion molecule influences haemopoietic progenitor binding to marrow stroma in chronic myeloid leukaemia Leukemia 5(8): 693-698
Sugihara, T.; Saito, H. 1987: Application of a monoclonal antibody against factor XIi (Hageman factor); enzyme-linked immunosorbent assay (ELISA) for factor XIi antigen Nihon Ketsueki Gakkai Zasshi: Journal of Japan Haematological Society 50(3): 691-695
Wiley, J.S.; Cebon, J.S.; Jamieson, G.P.; Szer, J.; Gibson, J.; Woodruff, R.K.; McKendrick, J.J.; Sheridan, W.P.; Biggs, J.C.; Snook, M.B. 1994: Assessment of proliferative responses to granulocyte-macrophage colony-stimulating factor (GM-CSF) in acute myeloid leukaemia using a fluorescent ligand for the nucleoside transporter Leukemia 8(1): 181-185
Vachharajani, S.D.; Rastogi, D.S. 1976: Co-existent pulmonary tuberculosis and myeloid leukaemia--a case report Indian Journal of Chest Diseases and Allied Sciences 18(1): 56-58
Mohd Ridzuan, M.S.; Yap, E.; Wan Fariza, W.J.; Fadilah, S.A.W.; Salwati, S. 2016: A case of chronic myeloid leukaemia in blast transformation with leukemic ascites Medical Journal of Malaysia 71(2): 85-87
Leong, C.F.; Azma, R.Z.; Cheong, S.K.; Salwati, S.; Sharifah, N.A. 2005: Complex karyotypic abnormalities in a case of acute myeloid leukaemia--M4Eo Malaysian Journal of Pathology 27(1): 45-50
Wanvarie, S.; Limsuwan, A.; Tanphaichitr, D. 1978: Salmonellosis with marked leukocytosis: a case of chronic myeloid leukaemia associated with Salmonella infection Southeast Asian Journal of Tropical Medicine and Public Health 9(4): 536-538
Dutta, T.K.; Purohit, O.P.; Vaidyanathan, V.; Gupta, B.D.; Rao, M.S. 1979: Radiation therapy of priaprism complicating chronic myeloid leukaemia--review and report of a case Indian Journal of Cancer 16(3-4): 90-93
Kueh, Y.K.; Tan, Y.O.; Wang, T.L.; Chan, R.; Suri, R. 1991: Prognostic usefulness of cytogenetic analysis for haematological malignancies--two case reports on acute myeloid leukaemia Annals of the Academy of Medicine Singapore 20(3): 389-393
España, F.; Ratnoff, O.D. 1983: Activation of Hageman factor (factor XII) by sulfatides and other agents in the absence of plasma proteases Journal of Laboratory and Clinical Medicine 102(1): 31-45
Shibayama, Y.; Brunnee, T.; Kaplan, A.P.; Reddigari, S. 1994: Activation of human Hageman factor (factor XII) in the presence of zinc and phosphate ions Brazilian Journal of Medical and Biological Research 27(8): 1817-1828
Gordon, E.M.; Johnson, T.R.; Ramos, L.P.; Schmeidler-Sapiro, K.T. 1991: Enhanced expression of factor XIi (Hageman factor) in isolated livers of estrogen- and prolactin-treated rats Journal of Laboratory and Clinical Medicine 117(5): 353-358
Herold, R.; Straub, P.W. 1972: In vivo role of factor XIi (Hageman factor) in hypercoagulability and fibrinolysis Journal of Laboratory and Clinical Medicine 79(3): 397-412
Laurel, M.T.; Ratnoff, O.D.; Everson, B. 1992: Inhibition of the activation of Hageman factor (factor XII) by aprotinin (Trasylol) Journal of Laboratory and Clinical Medicine 119(5): 580-585